The proteasome regulator PSME4 modulates proteasome activity and antigen diversity to abrogate antitumor immunity in NSCLC-Reference-Cited by-同舟云学术

The proteasome regulator PSME4 modulates proteasome activity and antigen diversity to abrogate antitumor immunity in NSCLC

Published:2023-05-22 Issue:5 Volume:4 Page:629-647
ISSN:2662-1347
Container-title:Nature Cancer
language:en
Short-container-title:Nat Cancer

Author:

Javitt Aaron^ORCID,Shmueli Merav D.^ORCID,Kramer Matthias P.^ORCID,Kolodziejczyk Aleksandra A.^ORCID,Cohen Ivan J.,Radomir Lihi,Sheban Daoud,Kamer Iris,Litchfield Kevin^ORCID,Bab-Dinitz Elizabeta,Zadok Oranit,Neiens Vanessa,Ulman Adi^ORCID,Wolf-Levy Hila,Eisenberg-Lerner Avital,Kacen Assaf^ORCID,Alon Michal,Rêgo Ana Toste,Stacher-Priehse Elvira,Lindner Michael,Koch Ina^ORCID,Bar Jair^ORCID,Swanton Charles^ORCID,Samuels Yardena^ORCID,Levin Yishai,da Fonseca Paula C. A.,Elinav Eran^ORCID,Friedman Nir,Meiners Silke^ORCID,Merbl Yifat^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

https://www.nature.com/articles/s43018-023-00557-4.pdf

Reference84 articles.

1. Johnson, D. B., Nebhan, C. A., Moslehi, J. J. & Balko, J. M. Immune-checkpoint inhibitors: long-term implications of toxicity. Nat. Rev. Clin. Oncol. 19, 254–267 (2022).

2. Rock, K. L., Reits, E. & Neefjes, J. Present yourself! By MHC class I and MHC class II molecules. Trends Immunol. 37, 724–737 (2016).

3. Rousseau, A. & Bertolotti, A. Regulation of proteasome assembly and activity in health and disease. Nat. Rev. Mol. Cell Biol. 19, 697–712 (2018).

4. Salzmann, U. et al. Mutational analysis of subunit iβ2 (MECL-1) demonstrates conservation of cleavage specificity between yeast and mammalian proteasomes. FEBS Lett. 454, 11–15 (1999).

5. Driscoll, J., Brown, M. G., Finley, D. & Monaco, J. J. MHC-linked LMP gene products specifically alter peptidase activities of the proteasome. Nature 365, 262–264 (1993).

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Quantitative mapping of proteasome interactomes and substrates using ProteasomeID;eLife;2024-09-04

2. Quantitative mapping of proteasome interactomes and substrates using ProteasomeID;eLife;2024-09-04

3. Immune checkpoint blockade resistance in lung cancer: emerging mechanisms and therapeutic opportunities;Trends in Pharmacological Sciences;2024-06

4. PA200-Mediated Proteasomal Protein Degradation and Regulation of Cellular Senescence;International Journal of Molecular Sciences;2024-05-22

5. ProteasomeID: quantitative mapping of proteasome interactomes and substrates for in vitro and in vivo studies;2024-05-01